Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- Walmart Health's medical provider has quietly filed to operate in 16 more states;
- We just got more evidence both vaccine doses of Pfizer's COVID-19 shot may be needed to protect against variants;
- Your guide to traveling safely this summer.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
Walmart is quietly laying plans to care for patients in 16 more states as it pushes into online care
- Walmart Health's medical provider has filed to operate in 16 more states, an Insider review found.
- A Walmart spokesperson said the filings are related to the company's push into virtual care.
- Walmart signaled that push when it unveiled plans in May to buy telehealth company MeMD.
There's more evidence that getting both doses of Pfizer's vaccine may be 'critical' to protecting against emerging variants
- Pfizer's vaccine worked against five coronavirus variants in the first lab study to directly compare them.
- It added more evidence that both doses may be needed to protect against emerging variants.
- Most people who get two doses would be protected against the variant initially from India, the researchers said.
A travel-safety guide for vaccinated people: How to keep your stress level and infection risk low this summer
- As people begin to travel more, there are ways to fly safely without going overboard, experts say.
- Flying is relatively low-risk for vaccinated people, even in crowded airports.
- It's no longer critical to social distance on planes, but keep your mask on and minimize layovers.
Here's what you need to know>>
More stories we're reading:
- Meghan Markle gave birth to son Archie in the UK and will have her daughter in the US. Here's how childbirth differs in the countries. (Insider)
- DNA-testing company Helix raised $50 million (GenomeWeb)
- Fauci: We need to keep an 'open mind' about the lab-leak theory of the coronavirus pandemic's origins (Insider)
- A new Alzheimer's FDA approval could deepen the racial inequalities that persist in dementia care (Stat News)
- Lydia
Read the original article on Business Insider